Oral antiviral molnupiravir gets interim authorisation for Covid-19 treatment in S'pore - The Straits Times

It will be prescribed and prioritised for those at higher risk of severe illness. . Read more at straitstimes.com.

SINGAPORE - A second oral antiviral medicine has been authorised in Singapore for the treatment of mild to moderate Covid-19 in individuals aged 18 years and above. Molnupiravir, which is sold under… [+2515 chars]

full article...